Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schade

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|December 28, 1974
Decreased glucagon activity: A mechanism for genetic and acquired endogenous hyperlipaemiaR P Eaton, D S Schade, M Conway
Metabolism: Clinical and Experimental|August 1, 1979
The role of glucagon in the regulation of plasma lipidsD S Schade, W Woodside, R P Eaton
Cardiovascular Drugs and Therapy|July 8, 2024
Reducing Cardiovascular Disease-An Alternative ApproachHetal Boricha, James C Blankenship, David S Schade
The American Journal of Medicine|September 3, 2023
Interpreting the Coronary Artery Calcium Score - Critical Information for the Practicing PhysicianDavid S Schade, Martin Hickey, R Philip Eaton
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Cholesterol Review: A Metabolically Important MoleculeDavid S Schade, Lynda Shey, R Philip Eaton
Rocky Mountain Medical Journal|November 1, 1977
Diabetic ketoacidosis: counter-regulatory hormones versus insulin in therapeutic response. Report of a caseD S Schade, E Kaufman, R P Eaton
Diabetes Care|January 1, 1980
Normalization of plasma insulin profiles in diabetic subjects with programmed insulin deliveryD S Schade, R P Eaton, W Spencer
Metabolism: Clinical and Experimental|March 1, 1976
Altered insulin and glucagon secretion in treated genetic hyperlipemia: a mechanism of theraphy?R P Eaton, R Oase, D S Schade
The American Journal of Medicine|September 2, 2020
The ReplyDavid S Schade, Sanjeev Arora, R Philip Eaton
The American Journal of Medicine|November 11, 2020
Stop Stenting; Start Reversing AtherosclerosisDavid S Schade, Kristen Gonzales, R Philip Eaton
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|December 28, 1974
Decreased glucagon activity: A mechanism for genetic and acquired endogenous hyperlipaemiaR P Eaton, D S Schade, M Conway
Metabolism: Clinical and Experimental|August 1, 1979
The role of glucagon in the regulation of plasma lipidsD S Schade, W Woodside, R P Eaton
Cardiovascular Drugs and Therapy|July 8, 2024
Reducing Cardiovascular Disease-An Alternative ApproachHetal Boricha, James C Blankenship, David S Schade
The American Journal of Medicine|September 3, 2023
Interpreting the Coronary Artery Calcium Score - Critical Information for the Practicing PhysicianDavid S Schade, Martin Hickey, R Philip Eaton
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Cholesterol Review: A Metabolically Important MoleculeDavid S Schade, Lynda Shey, R Philip Eaton
Rocky Mountain Medical Journal|November 1, 1977
Diabetic ketoacidosis: counter-regulatory hormones versus insulin in therapeutic response. Report of a caseD S Schade, E Kaufman, R P Eaton
Diabetes Care|January 1, 1980
Normalization of plasma insulin profiles in diabetic subjects with programmed insulin deliveryD S Schade, R P Eaton, W Spencer
Metabolism: Clinical and Experimental|March 1, 1976
Altered insulin and glucagon secretion in treated genetic hyperlipemia: a mechanism of theraphy?R P Eaton, R Oase, D S Schade
The American Journal of Medicine|September 2, 2020
The ReplyDavid S Schade, Sanjeev Arora, R Philip Eaton
The American Journal of Medicine|November 11, 2020
Stop Stenting; Start Reversing AtherosclerosisDavid S Schade, Kristen Gonzales, R Philip Eaton
Pageof 21